Despite the growing interest of the scientific community in understanding LRP-1 functionalities in tumour progression and resistance to treatments, the role of LRP-1 in the regulation of EGFR trafficking and glioma cell resistance to TKI had never been addressed so far. This evidence concerns the gene EGFR and neoplasm.